| ²é¿´: 1570 | »Ø¸´: 6 | ||
°ëµ÷×Ó÷»¨Ìú³æ (³õÈëÎÄ̳)
|
[½»Á÷]
apolipoprotein b µÄ·Ö×ÓÁ¿ÊǶàÉÙ£¿
|
¡ï
°ëµ÷×Ó÷»¨(½ð±Ò+1): лл²ÎÓë
°ëµ÷×Ó÷»¨(½ð±Ò+1): лл²ÎÓë
|
2Â¥2015-11-05 21:28:21
3Â¥2015-11-05 21:30:13
|
4Â¥2015-11-05 21:42:12
| Ŷ £¡ |
5Â¥2015-11-05 21:55:42
mascotte
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 10 (Ó×¶ùÔ°)
- ½ð±Ò: 1998.9
- ºì»¨: 3
- Ìû×Ó: 328
- ÔÚÏß: 193.4Сʱ
- ³æºÅ: 492008
- ×¢²á: 2008-01-07
- רҵ: ÉúÎﻯѧ
¡ï ¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
°ëµ÷×Ó÷»¨: ½ð±Ò+3 2015-11-09 14:32:14
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
°ëµ÷×Ó÷»¨: ½ð±Ò+3 2015-11-09 14:32:14
| Human apoB-100 is a glycoprotein with a molecular mass of about 550 kDa, consisting of 4536 amino acid residues. Both ApoB-48 and ApoB-100 are coded by APOB and by a single mRNA transcript larger than 16 kb. ApoB-48 is generated when a stop codon (UAA) at residue 2153 is created by RNA editing. As a result of the RNA editing, ApoB-48 and ApoB-100 share a common N-terminal sequence, but ApoB-48 lacks ApoB-100's C-terminal LDL receptor binding region. In fact, ApoB-48 is so called because it constitutes 48% of the sequence for ApoB-100. |
6Â¥2015-11-07 04:26:11
°ëµ÷×Ó÷»¨
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 43.3
- É¢½ð: 5
- Ìû×Ó: 30
- ÔÚÏß: 7.4Сʱ
- ³æºÅ: 2390207
- ×¢²á: 2013-03-31
- רҵ: ÉúÎïÎïÀí¡¢ÉúÎﻯѧÓë·Ö×Ó
7Â¥2015-11-09 14:39:56














»Ø¸´´ËÂ¥
»¹ÊDz»ÄܽâÊÍÎҵĽá¹û
»¹ÊÇллÄãÁË¡£